Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2009

01.11.2009 | Preclinical Study

Intraductal approach to the detection of intraductal lesions of the breast

verfasst von: Tadaharu Matsunaga, Takeharu Misaka, Katsumasa Hosokawa, Shinichiro Taira, Kyeongil Kim, Hiromi Serizawa, Hutoshi Akiyama, Masahiko Fujii

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Bloody nipple discharge is a clue in the detection of ductal carcinoma of the breast that do not display a mass. Since sensitivity of discharge cytology is not sufficiently high and mammary ductendoscopy (MS) contributes to the diagnosis of intraductal lesions. We set out to determine whether the intraductal approach is effective for detection of ductal carcinoma. We performed 445 MS procedure in 323 patients who had nipple discharge but no overt mass. The diagnostic accuracy rates of discharge cytology and intraductal breast biopsy (IDBB) were studied in detecting malignancy. The therapeutic value of IDBB for intraductal papillomas was studied in 73 patients. Out of 323 patients, 80 had breast cancer and 155 had intraductal papilloma. MS detected intraductal tumors in 47 cases (58.8%). IDBB was performed in 35 of these 47 cases. The sensitivity was 37.1% by touch cytology, 68.6% by IDBB, and 82.8% by directed ductal lavage cytology. Of the 73 intraductal papilloma patients who were followed for more than 3 years, the therapeutic effectiveness of IDBB was recognized in 57 (78.1%). Directed ductal lavage cytology was the most sensitive method in detecting malignancy. MS and IDBB were benefit in the treatment of intraductal papilloma.
Literatur
1.
Zurück zum Zitat Teboul M (1988) A new concept in breast investigation: echo-histological acino-ductal analysis or analytic echography. Biomed Pharmacother 42:282–296 Teboul M (1988) A new concept in breast investigation: echo-histological acino-ductal analysis or analytic echography. Biomed Pharmacother 42:282–296
2.
Zurück zum Zitat Namba K, Sakamoto G, Akiyama F, Makita M, Sugano H, Kasumi H et al (1989) Intraductal biopsy of the breast (IDBB) for intraductal lesions: a case of breast cancer diagnosed by IDBB. Jpn J Breast Cancer 4:253–258 Namba K, Sakamoto G, Akiyama F, Makita M, Sugano H, Kasumi H et al (1989) Intraductal biopsy of the breast (IDBB) for intraductal lesions: a case of breast cancer diagnosed by IDBB. Jpn J Breast Cancer 4:253–258
3.
Zurück zum Zitat Makita M, Sakamoto G, Akiyama F, Namba K, Sugano H, Kasumi F et al (1991) Duct endoscopy and endoscopic biopsy in the evaluation of nipple discharge. Breast Cancer Res Treat 18:179–188. doi:10.1007/BF01990034 CrossRefPubMed Makita M, Sakamoto G, Akiyama F, Namba K, Sugano H, Kasumi F et al (1991) Duct endoscopy and endoscopic biopsy in the evaluation of nipple discharge. Breast Cancer Res Treat 18:179–188. doi:10.​1007/​BF01990034 CrossRefPubMed
4.
Zurück zum Zitat Okazaki A, Okazaki M, Asaishi K, Satoh H, Watanabe Y, Mikami T et al (1991) Fiberoptic ductoscopy of the breast: a new diagnostic procedure for nipple discharge. Jpn J Clin Oncol 21:188–193PubMed Okazaki A, Okazaki M, Asaishi K, Satoh H, Watanabe Y, Mikami T et al (1991) Fiberoptic ductoscopy of the breast: a new diagnostic procedure for nipple discharge. Jpn J Clin Oncol 21:188–193PubMed
6.
Zurück zum Zitat Nagase J, Endo M (1995) Endoscopic biopsy in the intraductal lesions of the breast for the mammary duct fiberscope. Jpn J Breast Cancer 10:405–409 Nagase J, Endo M (1995) Endoscopic biopsy in the intraductal lesions of the breast for the mammary duct fiberscope. Jpn J Breast Cancer 10:405–409
8.
Zurück zum Zitat Shen KW, Jiong Wu, Lu JS, Han QX, Shen ZZ, Nguyen M, Shao ZM, Barsky SH (2000) Fiberoptic ductoscopy for patients with nipple discharge. Cancer 89:1512–1519. doi:10.1002/1097-0142(20001001)89:7<1512::AID-CNCR14>3.0.CO;2-LCrossRefPubMed Shen KW, Jiong Wu, Lu JS, Han QX, Shen ZZ, Nguyen M, Shao ZM, Barsky SH (2000) Fiberoptic ductoscopy for patients with nipple discharge. Cancer 89:1512–1519. doi:10.1002/1097-0142(20001001)89:7<1512::AID-CNCR14>3.0.CO;2-LCrossRefPubMed
9.
Zurück zum Zitat Yamamoto D, Shoji T, Kawanishi H, Nakagawa H, Haijima H, Gondo H et al (2001) A utility of ductography and fiberoptic ductoscopy for patients with nipple discharge. Breast Cancer Res Treat 70:103–108. doi:10.1023/A:1012990809466 CrossRefPubMed Yamamoto D, Shoji T, Kawanishi H, Nakagawa H, Haijima H, Gondo H et al (2001) A utility of ductography and fiberoptic ductoscopy for patients with nipple discharge. Breast Cancer Res Treat 70:103–108. doi:10.​1023/​A:​1012990809466 CrossRefPubMed
10.
Zurück zum Zitat Matsunaga T, Ohta D, Misaka T, Hosokawa K, Fujii M, Nakayama S et al (2001) Mammary ductoscopy for diagnosis and treatment of intraductal lesions of the breast. Breast Cancer 8:213–221CrossRefPubMed Matsunaga T, Ohta D, Misaka T, Hosokawa K, Fujii M, Nakayama S et al (2001) Mammary ductoscopy for diagnosis and treatment of intraductal lesions of the breast. Breast Cancer 8:213–221CrossRefPubMed
12.
Zurück zum Zitat Dooley WC (2002) Routine operative breast endoscopy for bloody nipple discharge. Ann Surg Oncol 9:920–923CrossRefPubMed Dooley WC (2002) Routine operative breast endoscopy for bloody nipple discharge. Ann Surg Oncol 9:920–923CrossRefPubMed
13.
Zurück zum Zitat Dooley WC (2003) Routine operative breast endoscopy during lumpectomy. Ann Surg Oncol 10:38–42CrossRefPubMed Dooley WC (2003) Routine operative breast endoscopy during lumpectomy. Ann Surg Oncol 10:38–42CrossRefPubMed
15.
Zurück zum Zitat Sarakbi WA, Salhab M, Mokbel K (2006) Does mammary ductoscopy have a role in clinical practice? Int Semin Surg Oncol 3:16CrossRefPubMed Sarakbi WA, Salhab M, Mokbel K (2006) Does mammary ductoscopy have a role in clinical practice? Int Semin Surg Oncol 3:16CrossRefPubMed
16.
Zurück zum Zitat Danforth DN, Abati A, Filie A, Prindiville SA, Palmieri D, Simon R, Ried T, Steeg PS (2006) Combined breast ductal lavage and ductal endoscopy for the evaluation of the high-risk breast: a feasibility study. J Surg Oncol 94:555–564CrossRefPubMed Danforth DN, Abati A, Filie A, Prindiville SA, Palmieri D, Simon R, Ried T, Steeg PS (2006) Combined breast ductal lavage and ductal endoscopy for the evaluation of the high-risk breast: a feasibility study. J Surg Oncol 94:555–564CrossRefPubMed
17.
Zurück zum Zitat Escobar PF, Crowe JP, Matsunaga T, Mokbel K (2006) The clinical applications of mammary ductoscopy. Am J Surg 191:211–215CrossRefPubMed Escobar PF, Crowe JP, Matsunaga T, Mokbel K (2006) The clinical applications of mammary ductoscopy. Am J Surg 191:211–215CrossRefPubMed
18.
Zurück zum Zitat Mokbel K, Escobar PF, Matsunaga T (2005) Mammary ductoscopy: current status and future prospects. Eur J Surg Oncol 331:3–8CrossRef Mokbel K, Escobar PF, Matsunaga T (2005) Mammary ductoscopy: current status and future prospects. Eur J Surg Oncol 331:3–8CrossRef
19.
Zurück zum Zitat Zhi-Ming S, Mai N (2001) Nipple aspiration in diagnosis of breast cancer. Semin Surg Oncol 20:175–180CrossRef Zhi-Ming S, Mai N (2001) Nipple aspiration in diagnosis of breast cancer. Semin Surg Oncol 20:175–180CrossRef
20.
Zurück zum Zitat Dooley WC, Ljung BM, Veronesi U, Cazzaniga M, Elledge RM, O’Shaughnessy JA, Kuerer HM, Hung DT, Khan SA, Philips RF, Ganz PA, Euhus DM, Esserman LJ, Haffty BG, King BL, Kelly MC, Anderson MM, Schmit PJ, Clark RR, Kass FC, Anderson BO, Troyan SL, Arias RD, Quiring JN, Love SM, Page DL, King EB (2001) Ductal lavage for detection of cellular atypia in woman at high risk for breast cancer. J Natl Cancer Inst 93:1624–1632PubMedCrossRef Dooley WC, Ljung BM, Veronesi U, Cazzaniga M, Elledge RM, O’Shaughnessy JA, Kuerer HM, Hung DT, Khan SA, Philips RF, Ganz PA, Euhus DM, Esserman LJ, Haffty BG, King BL, Kelly MC, Anderson MM, Schmit PJ, Clark RR, Kass FC, Anderson BO, Troyan SL, Arias RD, Quiring JN, Love SM, Page DL, King EB (2001) Ductal lavage for detection of cellular atypia in woman at high risk for breast cancer. J Natl Cancer Inst 93:1624–1632PubMedCrossRef
21.
Zurück zum Zitat Ljung BM, Chew L, Moore DH II, King EB (2004) Cytology of ductal lavage fluid of the breast. Diagn Cytopathol 30:143–150CrossRefPubMed Ljung BM, Chew L, Moore DH II, King EB (2004) Cytology of ductal lavage fluid of the breast. Diagn Cytopathol 30:143–150CrossRefPubMed
22.
Zurück zum Zitat Wrensch MR, Petrakis NL, King EB, Miike R, Mason L, Chew KL, Lee MM, Emster VL, Hilton JF, Schweitzer R, Goodson WH III, Hunt TK (1992) Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol 135:130–141PubMed Wrensch MR, Petrakis NL, King EB, Miike R, Mason L, Chew KL, Lee MM, Emster VL, Hilton JF, Schweitzer R, Goodson WH III, Hunt TK (1992) Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol 135:130–141PubMed
23.
Zurück zum Zitat Wrensch MR, Petrakis NL, Miike R, King EB, Chew K, Neuhaus J, Lee MM, Rhys M (2001) Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natl Cancer Inst 93:1791–1798CrossRefPubMed Wrensch MR, Petrakis NL, Miike R, King EB, Chew K, Neuhaus J, Lee MM, Rhys M (2001) Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natl Cancer Inst 93:1791–1798CrossRefPubMed
Metadaten
Titel
Intraductal approach to the detection of intraductal lesions of the breast
verfasst von
Tadaharu Matsunaga
Takeharu Misaka
Katsumasa Hosokawa
Shinichiro Taira
Kyeongil Kim
Hiromi Serizawa
Hutoshi Akiyama
Masahiko Fujii
Publikationsdatum
01.11.2009
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2009
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-0203-2

Weitere Artikel der Ausgabe 1/2009

Breast Cancer Research and Treatment 1/2009 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.